HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse Events Spark FDA Evaluation Of Topical Acne Ingredients

This article was originally published in The Rose Sheet

Executive Summary

A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.

You may also be interested in...



OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA

Manufacturers of OTC topical acne drug products should consider including text on labeling that instructs new uses in sensitivity testing “to reduce the risk of serious hypersensitivity reactions,” FDA says.

Natural OTCs Sprout From Firms’ Innovations Within Monograph Limits

Recently launched OTCs from Earth’s Care and LaCorium Health target consumers who want natural products with the safety and efficacy assured under FDA’s drug monographs. Supplement and homeopathic product makers also target consumers with natural alternatives to traditional pharmaceuticals.

Natural OTCs Sprout From Firms’ Innovations Within Monograph Limits

Recently launched OTCs from Earth’s Care and LaCorium Health target consumers who want natural products with the safety and efficacy assured under FDA’s drug monographs. Supplement and homeopathic product makers also target consumers with natural alternatives to traditional pharmaceuticals.

Related Content

Related Companies

UsernamePublicRestriction

Register

PS026881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel